iBio, Inc. (IBIO) › Operating IncomeiBio, Inc. (IBIO) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2011: -$9.65M2012: -$9.33M2013: -$6.67M2014: -$3.84M2015: -$6.67M2016: -$9.89M2017: -$14.27M2018: -$14.23M2019: -$15.79M2020: -$14.00M2021: -$31.11M2022: -$29.70M2023: -$29.34M2024: -$16.63M2025: -$18.60M-$18.60M2011Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$18.60M-11.8%2024-$16.63M+43.3%2023-$29.34M+1.2%2022-$29.70M+4.5%2021-$31.11M-122.2%2020-$14.00M+11.3%2019-$15.79M-11.0%2018-$14.23M+0.3%2017-$14.27M-44.3%2016-$9.89M-48.4%2015-$6.67M-73.6%2014-$3.84M+42.4%2013-$6.67M+28.5%2012-$9.33M+3.4%2011-$9.65M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share